THIRTEEN new Ozempic-like drugs are coming in the next few years as part of weight-loss goldrush

Drugmakers like Novo Nordisk and Amgen are capitalizing on the success of groundbreaking obesity drugs with plans to release an additional 13 treatments in the coming years.Drugmakers like Novo Nordisk and Amgen are capitalizing on the success of groundbreaking obesity drugs with plans to release an additional 13 treatments in the coming years.Read MoreHealth News | Mail Online